Contact dermatitis: a practice parameter.
D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D000465:Algorithms; D018926:Anti-Allergic Agents / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003358:Cosmetics / Q000009:adverse effects; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000628:therapy; D003877:Dermatitis, Contact / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D003937:Diagnosis, Differential; D004198:Disease Susceptibility; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D010328:Patch Tests; D010944:Plants / Q000009:adverse effects / Q000737:chemistry; D011379:Prognosis; D019736:Prostheses and Implants / Q000009:adverse effects; D013259:Steroids, Fluorinated / Q000008:administration & dosage / Q000627:therapeutic use
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D003358:Cosmetics; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D013259:Steroids, Fluorinated